Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses the next treatment steps for a patient with HER2-negative chemotherapy-resistant metastatic breast cancer.
Ragene Rivera, MD
Articles by Ragene Rivera, MD
Ragene Rivera, MD, medical oncologist, Texas Oncology-El Paso Cancer Treatment Center, discusses how she decides between hormone therapies in patients with ER+/PR+ tumors.
Latest Updated Articles
Treating a Patient With HER2-Negative Chemotherapy-Resistant mBCAugust 12th 2014
